Treatment of Lung Adenocarcinoma - EPO Patent from TRUSTLIFEThe present disclosure provides CGP-60474 for use in a method of prevention or treatment of lung adenocarcinoma and mitoxantrone for use in a method of treatment of stage o or I lung adenocarcinoma.
